Status:
COMPLETED
Letrozole as a Treatment of Endometrial Cancer
Lead Sponsor:
University of California, Davis
Conditions:
Endometrial Carcinoma
Eligibility:
FEMALE
40+ years
Phase:
NA
Brief Summary
Some cases of endometrial cancer are dependent on estrogen for their growth. Letrozole blocks estrogen production in the body. The purpose of this study is to determine if the investigators can predic...
Eligibility Criteria
Inclusion
- FIGO grade 1 or 2 endometrioid adenocarcinoma of the endometrium
- Post menopausal status must be demonstrated
- Signed informed consent
Exclusion
- FIGO grade 3 endometrioid adenocarcinoma or non-endometrioid cancers of the endometrium
- Younger than 40 or postmenopausal status not established
- Pregnant or breastfeeding
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00997373
Start Date
October 1 2009
End Date
September 1 2013
Last Update
May 30 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis
Sacramento, California, United States, 95817
2
University of California, Davis
Sacramento, California, United States, 95817